A biotech career can be challenging with the ups and downs of drug development and chasing approval for those therapies, FierceBiotech writes. Still, it adds, some people love a challenge.
It profiles 15 women in biotech "who have been doing some amazing things."
Shire's Susan Kilsby, for instance, engineered the $54.8 billion deal with AbbVie that gave shareholders £52.48 a share in cash and stock — more than AbbVie CEO Richard Gonzalez originally offered. Meanwhile, Cynthia Verst at Quintiles is growing that company's post-market study business by developing patient registries, examining outcomes data, and more.
Many of those profiled, FierceBiotech notes, attribute part of their success to working with their colleagues.
"There's nothing more powerful than having a team move toward something versus an individual," Eisai's Shaji Procida says. "Part of growing in your career is looking for moments of learning … so your breadth of experience can be wider when you grow into a leadership role."